GI Grand Rounds “Stratification of immune cells in chronic hepatitis: Consequences for liver cancer therapy"

Mathias Heikenwälder, PhD will present “Stratification of immune cells in chronic hepatitis: Consequences for liver cancer therapy". Dr. Heikenwälder is the head of the junior research group “Chronic Inflammation, Tissue Damage and Cancer“ at Helmholtz Zentrum München. He oversees a working group in Zurich, holds lectures in Paris, New York and Munich and is currently preparing a clinical trial. He was just awarded a prestigious Young Investigator ERC (European Research Council) ERC (European Research Council) Starting Grant. His motto is Carpe diem noctemque – seize the day and the night.